Wednesday, 28 February 2018
Worst is behind us in pharma, but it is better to wait and watch: Prashant Nair, Citi Research
In a chat with ET Now, Prashant Nair, Citi Research , says pharma is one sector where midcap companies have turned into largecap companies. That transition has happened fairly frequently.
You can read more here: Worst is behind us in pharma, but it is better to wait and watch: Prashant Nair, Citi Research
Subscribe to:
Post Comments (Atom)
Life insurers earn more in Oct selling lesser policies
The 24-company Indian life insurance industry closed last month with new business of Rs 22,776.03 crore, up by 31.87 per cent over the prev...
No comments:
Post a Comment